Lv11
40 积分 2025-01-06 加入
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
3小时前
已完结
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
1个月前
已完结
HER2-Positive Breast Cancer Treatment and Resistance
1个月前
已完结
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
4个月前
已完结
Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
4个月前
已完结
Pyrotinib plus capecitabine for human epidermal growth factor receptor 2-positive metastatic breast cancer after trastuzumab and taxanes (PHENIX): a randomized, double-blind, placebo-controlled phase 3 study
4个月前
已完结
Targeting HER2-positive breast cancer: advances and future directions
5个月前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
5个月前
已完结
Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases
5个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
7个月前
已完结
皖公网安备34019202002308
